Dupilumab was equally effective among all racial subgroups in clinical trials, but a direct comparison in daily practice is lacking. To investigate the effectiveness of dupilumab in patients with atopicdermatitis (AD) in the Netherlands and Japan over 80weeks of treatment. A longitudinal comparative cohort study was conducted in patients with AD who were treated with dupilumab in daily practice. We used linear mixed-effects models to determine changes over time. We found statistically significant differences in sex, disease onset, body mass index and therapeutic history between Dutch (n=208) and Japanese (n=153) patients. The baseline Eczema Area and Severity Index (EASI) score was higher in Japanese patients (23·8 vs. 14·8), while baseline Patient-Reported Outcome Measures (PROMs) were higher in Dutch patients. https://www.selleckchem.com/products/bi-3802.html EASI scores decreased quickly to a level indicating 'mild disease' (EASI < 7), and remained low in both countries. However, PROMs showed different trajectories with better scores in Japan. Dupilumab showed significant, comparable and sustained improvement of EASI scores in Japanese and Dutch patients. However, we found striking differences in the effect on PROMs between the countries, with a better outcome in Japanese patients. Dupilumab showed significant, comparable and sustained improvement of EASI scores in Japanese and Dutch patients. However, we found striking differences in the effect on PROMs between the countries, with a better outcome in Japanese patients. This study aimed to systematically evaluate the effectiveness of patient decision aids on knowledge, decisional conflict and decisional self-efficacy outcomes in patients with diabetes. A comprehensive database search was performed using the Web of Science, Cochrane Library, PubMed, Embase, PsycINFO (Ovid), CINAHL (EBASCO), CNKI, VIP, Wan Fang Database and the Ottawa Decision Aid Library Inventory (http//decisionaid.ohri.ca/index.html) from inception to 13 October 2019. Two reviewers independently searched databases, screened articles, extracted data and evaluated the risk bias of included studies. Then Rev Man 5.3 software was adopted for statistical analysis. Ten articles containing 1,452 people with diabetes were selected. The results of meta-analysis showed that patient decision aids had a positive effect on reducing decisional conflict and improving decisional self-efficacy among patients with type 2 diabetes. Meanwhile, this article also revealed that patient decision aids have beneficial short-term effects on improving knowledge, but there was no significant long-term effect. Patient decision aids are capable of becoming support tools to improve shared decision making. Further implementation studies are required to transform patient decision aids tools into clinical practice. Patient decision aids are capable of becoming support tools to improve shared decision making. Further implementation studies are required to transform patient decision aids tools into clinical practice. The mechanism of erectile dysfunction (ED) caused by low androgen status is not fully understood. To investigate whether low androgen status inhibits erectile function of rats by inducing pyroptosis in the corpus cavernosum (CC). Thirty-six eight-weeks-old healthy male Sprague-Dawley rats were equally divided into six groups sham-operated group (4w sham, 8w sham), castration group (4w cast, 8w cast), and castration + testosterone (T) group (4w cast + T, 8w cast + T). The rats in castration + T groups were injected with testosterone propionate subcutaneously every other day. After 4 and 8weeks, the ratio of maximum intracavernous pressure (ICPmax)/mean arterial pressure (MAP), the level of serum T, the concentration of nitric oxide (NO) and interleukin-1β (IL-1β), the expression of NOD-like receptor pyrin domain containing 3 (NLRP3), apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC), Caspase-1 p20, gasdermin D-N (GSDMD-N), transforming growth factor β1 (ing NO synthesis through pyroptosis of SMCs and ECs in the CC.Although polyvinyl alcohol and sodium alginate gel (PVA/SA) cell immobilization technology has been successfully applied in anaerobic ammonium oxidation (anammox) processes, there is no comprehensive evaluation of the PVASA ratio in PVA/SA gel beads. Therefore, to determine the optimal PVASA ratio, the nitrogen removal performance and structure of PVA/SA anammox gel beads under different PVASA ratios were studied through batch experiments. The results suggested that cell immobilization technology could significantly improve the nitrogen removal rate (NRR). PVA concentration was positively correlated with the proportion of -macropore in the gel beads but negatively correlated with mechanical strength. Despite having poor mechanical strength, PVA/SA (12%/2%) gel beads had the highest NRR owing to the increased pore size and were experimentally determined to be the most suitable concentration of immobilized carrier. UASB reactor tests showed that compared with anammox granular sludge, the response time of anammox PVA/SA (12%/2%) beads to increased nitrogen load was shorter and the specific anammox activity was higher. Candidatus "Jettenia" was the dominant bacterium in anammox gel beads, accounting for 37.96% of the community. This study provides a reference for preparing PVA/SA cell immobilization. PRACTITIONER POINTS Increasing the concentration of PVA can reduce the apoptosis of microorganisms during the gel process. The macropore of PVA/SA beads increased with the increase of the PVASA ratio. This study provides a reference for preparing PVA/SA gel beads immobilized anammox bacteria. Mid-regional pro-atrial natriuretic peptide (MR-proANP) is a strong prognostic marker in several inflammatory, respiratory and cardiovascular conditions, but has not been studied in COVID-19 yet. This prospective, observational study of patients with COVID-19 infection was conducted from 6 June to 26 November 2020 in different wards of a tertiary hospital. MR-proANP, N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitive cardiac troponin I levels on admission were collected and tested for their association with disease severity and 28-day mortality. A total of 213 eligible patients with COVID-19 were included in the final analyses of whom 13.2% (n=28) died within 28days. Median levels of MR-proANP at admission were significantly higher in nonsurvivors (307pmol/L IQR, [161 - 532] vs 75pmol/L [IQR, 43 - 153], P<.001) compared to survivors and increased with disease severity and level of hypoxaemia. The area under the ROC curve for MR-proANP predicting 28-day mortality was 0.832 (95% CI 0.